tuberculosis

Evaluation of a modified short all oral treatment regimen for rifampicin-multidrug resistant tuberculosis in Dominican Republic | BMC Infectious Diseases

by

Study design A prospective cohort study was conducted that enrolled patients with RR/MDR-TB between January and December 2022 in seven drug-resistant TB units in the Dominican Republic. The research protocol and data collection tools were developed using the Short all-Oral Regimens for Rifampicin-resistant Tuberculosis (ShoRRT) research package proposed by TDR [11], and adapted to the … Read more

AI-based technology accelerates discovery of new tuberculosis drug candidates

by

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes “TB” can lead to chronic cough, chest pains, fatigue, fever and weight loss. While infections are more extensive in other parts of the world, a serious tuberculosis … Read more

Groundbreaking trial finds levofloxacin effective against multidrug-resistant TB …

by

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug-resistant tuberculosis (TB), and almost halved adults’ and children’s risk of developing multidrug-resistant TB. “Multidrug-resistant TB is a major global public health problem, affecting over 400,000 people … Read more

Why bird flu could be the biggest health problem in 2025 – Firstpost

by

Malaria, tuberculosis and HIV claim number of lives in the world each year. But as the new year emerges, health professionals are more concerned about another infectious disease — bird flu — that is spreading rapidly across the globe read more Covid emerged suddenly, spread rapidly and killed millions of people around the world. Since … Read more